[go: up one dir, main page]

IT1277953B1 - Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per - Google Patents

Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per

Info

Publication number
IT1277953B1
IT1277953B1 IT95RM000835A ITRM950835A IT1277953B1 IT 1277953 B1 IT1277953 B1 IT 1277953B1 IT 95RM000835 A IT95RM000835 A IT 95RM000835A IT RM950835 A ITRM950835 A IT RM950835A IT 1277953 B1 IT1277953 B1 IT 1277953B1
Authority
IT
Italy
Prior art keywords
carnitine
polyunsatured
alcanoyl
pharmaceutical composition
composition containing
Prior art date
Application number
IT95RM000835A
Other languages
English (en)
Inventor
Claudio Cavazza
Menotti Calvani
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of ITRM950835A0 publication Critical patent/ITRM950835A0/it
Priority to IT95RM000835A priority Critical patent/IT1277953B1/it
Priority to DE69618158T priority patent/DE69618158T2/de
Priority to EP96118681A priority patent/EP0780124B1/en
Priority to PT96118681T priority patent/PT780124E/pt
Priority to AT96118681T priority patent/ATE210977T1/de
Priority to ES96118681T priority patent/ES2169197T3/es
Priority to DK96118681T priority patent/DK0780124T3/da
Priority to US08/755,310 priority patent/US5753703A/en
Priority to TW085114597A priority patent/TW522013B/zh
Priority to CA002191645A priority patent/CA2191645C/en
Priority to JP8335456A priority patent/JPH09176005A/ja
Priority to KR1019960067231A priority patent/KR970032853A/ko
Priority to ZA9610769A priority patent/ZA9610769B/xx
Publication of ITRM950835A1 publication Critical patent/ITRM950835A1/it
Application granted granted Critical
Publication of IT1277953B1 publication Critical patent/IT1277953B1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
IT95RM000835A 1995-12-21 1995-12-21 Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per IT1277953B1 (it)

Priority Applications (13)

Application Number Priority Date Filing Date Title
IT95RM000835A IT1277953B1 (it) 1995-12-21 1995-12-21 Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
DK96118681T DK0780124T3 (da) 1995-12-21 1996-11-21 Farmaceutisk præparat omfattende et alkanoyl-L-carnitin sammen med en polyumættet fedtsyre fra omega-3-serien til forebyggelse og behandling af lipidmetabolisme-lidelser
EP96118681A EP0780124B1 (en) 1995-12-21 1996-11-21 Pharmaceutical composition comprising an alkanoyl L-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders
PT96118681T PT780124E (pt) 1995-12-21 1996-11-21 Composicoes farmaceuticas compreendendo uma alcanoil-l-carnitina em combinacao com acidos gordos poliinsaturados da serie omega-3 para a prevencao e o tratamento das doencas do metabolismo lipidico
AT96118681T ATE210977T1 (de) 1995-12-21 1996-11-21 Pharmazeutische zusammensetzung enthaltend ein alkanoyl-l-carnitin in kombination mit einer polyungesättigten fettsäure der omega-3-serie zur verhütung und behandlung von störungen des fettstoffwechsels
ES96118681T ES2169197T3 (es) 1995-12-21 1996-11-21 Composicion farmaceutica que comprende una alcanoil l-carnitina en combinacion con un acido graso poliinsaturado de la serie omega-3 para la prevencion y el tratamiento de trastornos del metabolismo de los lipidos.
DE69618158T DE69618158T2 (de) 1995-12-21 1996-11-21 Pharmazeutische Zusammensetzung enthaltend ein Alkanoyl-L-Carnitin in Kombination mit einer polyungesättigten Fettsäure der Omega-3-Serie zur Verhütung und Behandlung von Störungen des Fettstoffwechsels
US08/755,310 US5753703A (en) 1995-12-21 1996-11-22 Pharmaceutical composition comprising L-carnitine or an alkanoyl L-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders
TW085114597A TW522013B (en) 1995-12-21 1996-11-26 Pharmaceutical composition comprising L-carnitine or an alkanoyl L-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders
CA002191645A CA2191645C (en) 1995-12-21 1996-11-29 Pharmaceutical composition comprising l-carnitine or an alkanoyl l-carnitine in combination with a polyunsaturated fatty acid of the omega-3 series for the prevention and the treatment of lipid metabolism disorders
JP8335456A JPH09176005A (ja) 1995-12-21 1996-12-16 オメガ−３系のポリ不飽和脂肪酸を併用するｌ−カルニチンまたはアルカノイル ｌ−カルニチン含有医薬組成物
KR1019960067231A KR970032853A (ko) 1995-12-21 1996-12-18 오메가-3계열의 고도불포화지방산과 l-카르니틴 또는 알카노일 l-카르니틴을 함유하는 지질대사질환의 예방 및 치료에 유용한 약제조성물
ZA9610769A ZA9610769B (en) 1995-12-21 1996-12-20 Pharmaceutical composition comprising l-carnitine or an alkanoyl l-carnitine in combination with a polyunsaturated fatty acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT95RM000835A IT1277953B1 (it) 1995-12-21 1995-12-21 Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per

Publications (3)

Publication Number Publication Date
ITRM950835A0 ITRM950835A0 (it) 1995-12-21
ITRM950835A1 ITRM950835A1 (it) 1997-06-21
IT1277953B1 true IT1277953B1 (it) 1997-11-12

Family

ID=11403724

Family Applications (1)

Application Number Title Priority Date Filing Date
IT95RM000835A IT1277953B1 (it) 1995-12-21 1995-12-21 Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per

Country Status (13)

Country Link
US (1) US5753703A (it)
EP (1) EP0780124B1 (it)
JP (1) JPH09176005A (it)
KR (1) KR970032853A (it)
AT (1) ATE210977T1 (it)
CA (1) CA2191645C (it)
DE (1) DE69618158T2 (it)
DK (1) DK0780124T3 (it)
ES (1) ES2169197T3 (it)
IT (1) IT1277953B1 (it)
PT (1) PT780124E (it)
TW (1) TW522013B (it)
ZA (1) ZA9610769B (it)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996022102A1 (fr) * 1995-01-18 1996-07-25 Taisho Pharmaceutical Co., Ltd. Remede contre l'eczema
IT1291113B1 (it) * 1997-03-20 1998-12-29 Sigma Tau Ind Farmaceuti Composizione nutritiva terapeutica per soggetti affetti da diabete mellito
US6403124B1 (en) 1997-04-16 2002-06-11 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Storage and maintenance of blood products including red blood cells and platelets
US6482585B2 (en) * 1997-04-16 2002-11-19 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Storage and maintenance of blood products including red blood cells and platelets
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
US5863940A (en) 1997-12-01 1999-01-26 Sigma-Tau Healthscience S.P.A. Medicament and therapeutical method for treating idiopathic asthenozoospermia
US20020002154A1 (en) * 1998-02-11 2002-01-03 Pol-Henri Guivarc'h Method and composition for treatment of inflammatory conditions
ATE254923T1 (de) 1998-03-19 2003-12-15 Sigma Tau Ind Farmaceuti Kombinierte zusammensetzung bestehend aus l- karnitin oder l-alkanoylkarnitin, einem glycosaminoglycan und/oder einem seiner bestandteile
IT1299161B1 (it) * 1998-04-17 2000-02-29 Sigma Tau Healthscience Spa Composizione comprendente l-carnitina o un'alcanoil l-carnitina e nadh e/o nadph
IT1302125B1 (it) * 1998-08-03 2000-07-31 Sigma Tau Healthscience Spa Composizione ad attivita' antiossidante ed antiproliferativacomprendente una carnitina ed un carotenoide
IT1308613B1 (it) * 1999-02-17 2002-01-09 Pharmacia & Upjohn Spa Acidi grassi essenziali nella prevenzione di eventi cardiovascolari.
IT1305308B1 (it) * 1999-03-26 2001-05-04 Biosint S P A Granulato ad alto contenuto di l-carnitina o alcanoil-l-carnitina,particolarmente adatto alla produzione di compresse per compressione
IT1317008B1 (it) * 2000-04-04 2003-05-26 Sigma Tau Healthscience Spa Integratore alimentare energizzante sulla muscolatura scheletrica eprotettivo sull'apparato cardiovascolare.
US8252309B2 (en) * 2000-04-04 2012-08-28 Sigma-Tau Industrie Farmaceutiche Riunite Spa Dietary supplement energy-providing to skeletal muscles
US7208180B2 (en) * 2000-05-08 2007-04-24 N.V. Nutricia Method and preparation for the preventing and/or treating vascular disorders and secondary disorders associated therewith
US7226916B1 (en) * 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
ITMI20010129A1 (it) 2001-01-25 2002-07-25 Pharmacia & Upjohn Spa Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco
WO2003009854A1 (en) * 2001-07-20 2003-02-06 Lonza Ag Lipid lowering composition comprising carnitine and phytosterol
ITMI20012384A1 (it) * 2001-11-12 2003-05-12 Quatex Nv Uso di acidi grassi poliinsaturi per la prevenzione primaria di eventi cardiovascolari maggiori
ES2208131B1 (es) * 2002-03-27 2005-09-01 Volker Bartz Metodo para la fabricacion de un medicamento reductor de niveles de lipidos en sangre para la administracion oral.
DE20214827U1 (de) 2002-09-25 2003-02-20 Bartz, Volker, 35440 Linden Leistungsförderer für Sportler zur oralen Einnahme
WO2004091603A1 (fr) * 2003-04-07 2004-10-28 Clinigenetics Utilisation d’un ester de dha pour le traitement des malades cardiovasculaires
EP1466597A1 (en) * 2003-04-07 2004-10-13 Clinigenetics Use of dha esters to control or prevent cardiovascular diseases
US8173618B2 (en) * 2003-07-25 2012-05-08 University Of Massachusetts Formulations for reducing neuronal degeneration
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
CN101242818B (zh) * 2005-07-08 2011-09-21 希格马托制药工业公司 包含L-肉碱或烷酰基L-肉碱、脂溶性苯醌和ω-3-多不饱和脂肪酸的组合用于制备治疗角膜疾病的膳食补充剂或药物的用途
US8853256B2 (en) 2006-05-31 2014-10-07 Mochida Pharmaceutical Co., Ltd. Composition for preventing the occurrence of cardiovascular event in multiple risk patient
JPWO2008093848A1 (ja) * 2007-02-02 2010-05-20 サンスター株式会社 ホスファチジルコリンを含有する炎症マーカー低減組成物
US8597640B2 (en) * 2007-10-31 2013-12-03 University Of Massachusetts Lowell Over-the-counter vitamin/nutriceutical formulation that provides neuroprotection and maintains or improves cognitive performance in alzheimer's disease and normal aging
CN102149376B (zh) 2008-08-07 2013-12-25 Spa抗菌素产品公司 症状性心力衰竭的长期治疗
MX2011004666A (es) * 2008-11-11 2011-05-31 Sigma Tau Ind Farmaceuti Compuesto util para tratar celulitis.
EP2355812B1 (en) * 2008-11-14 2019-07-10 Bomi P. Framroze Lowering circulating oxidized low density lipoprotein-beta-2-glycoprotein 1 complex for treatment of atherosclerosclerosis
CA2750153C (en) * 2009-01-05 2016-11-08 Calanus As Biological oil composition, formulations comprising the oil composition, and use thereof to prevent or treat cardiovascular disease
US9034389B2 (en) 2009-03-11 2015-05-19 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US8993625B2 (en) 2009-03-11 2015-03-31 Stable Solutions Llc Method of mitigating adverse drug events using omega-3 fatty acids as a parenteral therapeutic drug vehicle
US20110071090A1 (en) * 2009-03-11 2011-03-24 Stable Solutions Llc Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
ES2697533T3 (es) * 2009-06-12 2019-01-24 Calanus As Composición de aceite de copépodo, composiciones que comprenden la composición de aceite y su uso para reducir la acumulación de grasa visceral, mejorar la tolerancia a la glucosa y prevenir o tratar enfermedades y trastornos relacionados con la obesidad
US20110015154A1 (en) * 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20110098265A1 (en) * 2009-10-28 2011-04-28 Neuroscience, Inc. Methods for reducing cravings and impulses associated with addictive and compulsive behaviors
SI2704734T1 (sl) * 2011-05-03 2015-08-31 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Sestavek, uporaben za zdravljenje motenj lipidnega metabolizma
CN107028926A (zh) 2011-08-26 2017-08-11 国立大学法人大阪大学 糖尿病性心血管并发症的预防/治疗剂
GB201223370D0 (en) 2012-12-24 2013-02-06 Univ Tartu Method of treatment using lactobacillus fermentum ME-3
AU2013404985B2 (en) * 2013-11-05 2017-06-15 Hill's Pet Nutrition, Inc. Methods and compositions for improving kidney function
CA3073802A1 (en) 2017-08-23 2019-02-28 Gavish-Galilee Bio Applications Ltd. Compositions and methods for treating atherosclerotic cardiovascular disease

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56115736A (en) * 1980-02-19 1981-09-11 Kagakuhin Kensa Kyokai Separation and purification of eicosapentaenoic acid and docosahexaenoic acid
DE3026368A1 (de) * 1980-07-11 1982-02-18 Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion
EP0283513B1 (en) * 1986-09-17 1993-04-28 Clintec Nutrition Company Nutritional support or therapy for individuals at risk or under treatment for atherosclerotic, vascular, cardiovascular, and/or thrombotic diseases
US4918104A (en) * 1987-06-16 1990-04-17 Weiss Howard S Method and composition for increasing the concentration of omega-3 polyunsaturated fatty acids in poultry and poultry eggs and poultry and eggs resulting therefrom
DE3726299A1 (de) * 1987-06-26 1989-02-23 Dietl Hans Fettemulsion zur intravenoesen anwendung
JP2839276B2 (ja) * 1989-01-23 1998-12-16 日本分光工業株式会社 超臨界流体抽出・分離方法及び装置
US4968719A (en) * 1989-04-03 1990-11-06 Sigma Tau, Industrie Farmaceutiche Riunite Spa Method for treating vascular disease
JPH0394655A (ja) * 1989-09-06 1991-04-19 Otsuka Pharmaceut Co Ltd 栄養補給用組成物
DE4012894C2 (de) * 1990-04-23 1998-11-12 Werner Dr Gielsdorf Pharmazeutisches Mittel zur Behandlung von Störungen des Fettstoffwechsels
SE9101642D0 (sv) * 1991-05-30 1991-05-30 Kabi Pharmacia Ab Phospholipids
IT1254314B (it) * 1992-03-27 1995-09-14 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
IT1254331B (it) * 1992-04-23 1995-09-14 Sigma Tau Ind Farmaceuti Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico.
GB9214247D0 (en) * 1992-07-04 1992-08-19 Stephan Peter M Composition for use as a food or food supplement
US5308832A (en) * 1992-07-27 1994-05-03 Abbott Laboratories Nutritional product for persons having a neurological injury
IT1263004B (it) * 1992-10-08 1996-07-23 Sigma Tau Ind Farmaceuti Impiego della l-carnitina e acil l-carnitine nel trattamento a lungo termine di pazienti diabetici non insulino-dipendenti.
IT1256705B (it) * 1992-12-21 1995-12-12 Sigma Tau Ind Farmaceuti Procedimento per la preparazione di l-(-)-carnitina a partire da un prodotto di scarto avente opposta configurazione.

Also Published As

Publication number Publication date
ITRM950835A0 (it) 1995-12-21
CA2191645C (en) 2007-07-31
ES2169197T3 (es) 2002-07-01
DE69618158T2 (de) 2002-07-18
PT780124E (pt) 2002-06-28
DE69618158D1 (de) 2002-01-31
EP0780124A1 (en) 1997-06-25
EP0780124B1 (en) 2001-12-19
TW522013B (en) 2003-03-01
ITRM950835A1 (it) 1997-06-21
KR970032853A (ko) 1997-07-22
ZA9610769B (en) 1997-07-09
US5753703A (en) 1998-05-19
JPH09176005A (ja) 1997-07-08
DK0780124T3 (da) 2002-04-15
ATE210977T1 (de) 2002-01-15
CA2191645A1 (en) 1997-06-22

Similar Documents

Publication Publication Date Title
IT1277953B1 (it) Composizione farmaceutica contenente l-carnitina o una alcanoil l- carnitina e un acido poliinsaturo della serie 3-omega utile per
IT1276253B1 (it) Composizione farmaceutica contenente l-carnitina o alcanoil l-carnitine per la prevenzione ed il trattamento di stati morbosi
DE69720787D1 (de) Pharmazeutische zubereitung enhaltend eicosapentaensäure und/oder stearidonsäure
EP0764405A3 (en) Nutritional composition
PT1152755E (pt) Acidos gordos essenciais destinados a prevencao de acidentes cardio-vasculares
AU4485689A (en) Oral dosage forms of omega-3 polyunsaturated acids
BR0112073A (pt) Combinações terapêuticas de ácidos graxos
DE69506642D1 (de) Pharmazeutische Zubereitungen enthaltend mehrfach ungesättigte Fettsäuren zusammen mit antioxydativen Vitaminen und Provitaminen
EP3584235A3 (en) Resolvins: biotemplates for novel therapeutic interventions
YU59303A (sh) Esencijalne n-3 masne kiseline u lečenju srčane insuficijencije i manjkavosti rada srca
PE20001325A1 (es) Combinacion de cerivastatina y fibratos
GB8812653D0 (en) Pharmaceutical composition based on high concentration esters of docosahexaenoic acid
IT1294227B1 (it) Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione
IT1254314B (it) Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
EP1623708A3 (en) Pharmaceutical composition comprising acetyl L-carnitine in combination with a statine for treating pathologies brought about by an altered lipid metabolism
CA2162042A1 (en) Enteral Nutritional Product
NO932843L (no) Farmasoeytiske preparater
DK1414496T3 (da) Farmaceutisk sammensætning indeholdende en kombination af PPAR-alpha, pravastatin og mindst en polyglycoliseret glycerid
RU94008707A (ru) Готовые формы для снижения болезнетворного воздействия курения и способ применения их

Legal Events

Date Code Title Description
0001 Granted